Adam Benjamin

Adam Benjamin

InvestorPlace Assistant Editor

Adam Benjamin is Assistant Editor at InvestorPlace.com. He graduated from Seattle University with an honors degree in Creative Writing.

Recent Articles

Biotech Movers: Analyst Upgrades Lift Puma

By Adam Benjamin, InvestorPlace Assistant Editor

Shares of Puma, Array and Cadence rose in the wake of analyst upgrades, while Ariad and Idenix suffered setbacks.

EA Crashes … Are Consoles Next?

By Adam Benjamin, InvestorPlace Assistant Editor

Here’s a look at what the future of gaming could mean for Nintendo , Sony and Microsoft, plus a peek at a few wildcards that could disrupt the business.

Biotech Movers: Acadia Jumps, Affymax Crashes

By Adam Benjamin, InvestorPlace Assistant Editor

Last week, Acadia Pharmaceuticals rode the winds of good clinical results, while news of mass layoffs sent Affymax crashing again.

Biotech Movers: Spectrum, AEterna Among Big Losers

By Adam Benjamin, InvestorPlace Assistant Editor

A stopped phase 3 trial grounded AEterna Zentaris and a downshift in guidance kneecapped Spectrum Pharmaceuticals last week.

Load More